A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are ...
Feb 25, 2026
0
24
A new study has overcome a long-standing challenge: how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure. Researchers ...
Feb 24, 2026
0
20
Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting the gp120 on the viral ...
Feb 17, 2026
0
20
King's College London researchers have created a unique collection of human stem cell models that could help to uncover why HIV leads to different outcomes in different people. The research was carried out by Dr. Nathalia ...
Feb 13, 2026
0
8
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study, led by Professor Dr. Florian ...
Feb 12, 2026
0
25
The circumstances surrounding a study on a deadly virus could hardly have been more dramatic. One of its first authors was forced to flee his homeland when it became a war zone. More than 2,000 kilometers away, the laboratory ...
Feb 12, 2026
0
18
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein scaffolding that mimics ...
Feb 5, 2026
0
17
Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates. ...
Feb 3, 2026
0
139
Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, McGill University researchers report.
Jan 21, 2026
0
35
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired functionality—following the international gold standard for treating people with latent tuberculosis (TB) and HIV, a ...
Jan 15, 2026
0
23
